Mark McCann

2.0k total citations
30 papers, 1.2k citations indexed

About

Mark McCann is a scholar working on Clinical Biochemistry, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark McCann has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Clinical Biochemistry, 11 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark McCann's work include Metabolism and Genetic Disorders (17 papers), Amino Acid Enzymes and Metabolism (10 papers) and Neonatal Health and Biochemistry (10 papers). Mark McCann is often cited by papers focused on Metabolism and Genetic Disorders (17 papers), Amino Acid Enzymes and Metabolism (10 papers) and Neonatal Health and Biochemistry (10 papers). Mark McCann collaborates with scholars based in United States, Canada and Germany. Mark McCann's co-authors include Mendel Tuchman, Piero Rinaldo, Dietrich Matern, James Lymp, Si Houn Hahn, Jean M. Lacey, Carla Minutti, Mark J Magera, Mark R. Schleiss and M Tuchman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of Internal Medicine and Applied and Environmental Microbiology.

In The Last Decade

Mark McCann

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark McCann United States 20 548 517 223 206 191 30 1.2k
Michael Leichsenring Germany 23 506 0.9× 301 0.6× 212 1.0× 50 0.2× 107 0.6× 49 1.4k
Ellen Crushell Ireland 19 421 0.8× 302 0.6× 153 0.7× 112 0.5× 135 0.7× 61 1.1k
Tetsuya Ito Japan 22 582 1.1× 388 0.8× 136 0.6× 68 0.3× 86 0.5× 70 1.2k
Martti Kekomäki Finland 16 395 0.7× 300 0.6× 190 0.9× 252 1.2× 233 1.2× 59 1.2k
Derek A. Wong United States 20 289 0.5× 179 0.3× 88 0.4× 27 0.1× 237 1.2× 37 1.2k
Ronald Bellisario United States 19 549 1.0× 61 0.1× 180 0.8× 276 1.3× 94 0.5× 26 1.2k
Joseph L. Perrotto United States 13 538 1.0× 52 0.1× 103 0.5× 104 0.5× 199 1.0× 14 1.5k
S Mantagos Greece 14 226 0.4× 261 0.5× 95 0.4× 41 0.2× 59 0.3× 32 638
Patricia S. Latham United States 18 375 0.7× 81 0.2× 77 0.3× 54 0.3× 157 0.8× 58 1.1k
Barbara Döring Germany 18 243 0.4× 64 0.1× 174 0.8× 58 0.3× 252 1.3× 24 975

Countries citing papers authored by Mark McCann

Since Specialization
Citations

This map shows the geographic impact of Mark McCann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McCann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McCann more than expected).

Fields of papers citing papers by Mark McCann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark McCann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McCann. The network helps show where Mark McCann may publish in the future.

Co-authorship network of co-authors of Mark McCann

This figure shows the co-authorship network connecting the top 25 collaborators of Mark McCann. A scholar is included among the top collaborators of Mark McCann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark McCann. Mark McCann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schleiss, Mark R., Erin Osterholm, Ryan Shanley, et al.. (2025). Dried Blood Spot PCR for Detection of Congenital Cytomegalovirus Infection and Disease. JAMA Network Open. 8(8). e2529837–e2529837.
2.
Schleiss, Mark R., et al.. (2022). Assessment of Congenital Cytomegalovirus Prevalence Among Newborns in Minnesota During the COVID-19 Pandemic. JAMA Network Open. 5(9). e2230020–e2230020. 12 indexed citations
3.
Osterholm, Erin, Nelmary Hernandez-Alvarado, Mark McCann, et al.. (2021). #40: Does Cytomegalovirus (CMV) Viral Load Correlate with Disease Severity in the Setting of Congenital CMV (cCMV) Infection? Results from a Universal cCMV Screening Study. Journal of the Pediatric Infectious Diseases Society. 10(Supplement_2). S13–S14. 1 indexed citations
4.
Sarafoglou, Kyriakie, et al.. (2014). Comparison of Newborn Screening Protocols for Congenital Adrenal Hyperplasia in Preterm Infants. The Journal of Pediatrics. 164(5). 1136–1140. 23 indexed citations
5.
Sarafoglou, Kyriakie, et al.. (2012). Comparison of One-Tier and Two-Tier Newborn Screening Metrics for Congenital Adrenal Hyperplasia. PEDIATRICS. 130(5). e1261–e1268. 53 indexed citations
6.
Schimmenti, Lisa A., Mark R. Schleiss, Kathleen A. Daly, et al.. (2011). Evaluation of newborn screening bloodspot-based genetic testing as second tier screen for bedside newborn hearing screening. Genetics in Medicine. 13(12). 1006–1010. 25 indexed citations
7.
Choi, K. Yeon, Lisa A. Schimmenti, Anne M. Jurek, et al.. (2009). Detection of Cytomegalovirus DNA in Dried Blood Spots of Minnesota Infants Who Do Not Pass Newborn Hearing Screening. The Pediatric Infectious Disease Journal. 28(12). 1095–1098. 44 indexed citations
8.
Sarafoglou, Kyriakie, Amy Gaviglio, Krista Redlinger‐Grosse, et al.. (2009). High incidence of profound biotinidase deficiency detected in newborn screening blood spots in the Somalian population in Minnesota. Journal of Inherited Metabolic Disease. 32(S1). 169–173. 17 indexed citations
9.
Atwell, Thomas D., et al.. (2008). Neonatal Thyroid Function After Administration of IV Iodinated Contrast Agent to 21 Pregnant Patients. American Journal of Roentgenology. 191(1). 268–271. 58 indexed citations
10.
Schimmenti, Lisa A., Eric Crombez, Bernd Schwahn, et al.. (2006). Expanded newborn screening identifies maternal primary carnitine deficiency. Molecular Genetics and Metabolism. 90(4). 441–445. 72 indexed citations
11.
Minutti, Carla, Jean M. Lacey, Mark J Magera, et al.. (2004). Steroid Profiling by Tandem Mass Spectrometry Improves the Positive Predictive Value of Newborn Screening for Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 89(8). 3687–3693. 122 indexed citations
12.
Lacey, Jean M., Carla Minutti, Mark J Magera, et al.. (2004). Improved Specificity of Newborn Screening for Congenital Adrenal Hyperplasia by Second-Tier Steroid Profiling Using Tandem Mass Spectrometry. Clinical Chemistry. 50(3). 621–625. 168 indexed citations
13.
Tuchman, Mendel & Mark McCann. (1999). Phenylalanine and Tyrosine Quantification by Stable Isotope Dilution Liquid Chromatography–Mass Spectrometry from Filter Paper Blood Spots. Clinical Chemistry. 45(4). 571–573. 14 indexed citations
14.
Morizono, Hiroki, Mendel Tuchman, B. S. Rajagopal, et al.. (1997). Expression, purification and kinetic characterization of wild-type human ornithine transcarbamylase and a recurrent mutant that produces ‘late onset’ hyperammonaemia. Biochemical Journal. 322(2). 625–631. 38 indexed citations
15.
Morizono, Hiroki, B. S. Rajagopal, Mika Aoyagi, et al.. (1997). ‘Late Onset’ Ornithine Transcarbamylase Deficiency: Function of Three Purified Recombinant Mutant Enzymes. Human Molecular Genetics. 6(6). 963–968. 25 indexed citations
16.
McCann, Mark, et al.. (1996). Methylmalonic acid quantification by stable isotope dilution gas chromatography-mass spectrometry from filter paper urine samples. Clinical Chemistry. 42(6). 910–914. 19 indexed citations
17.
Tuchman, Mendel, et al.. (1994). Seven new mutations in the human ornithine transcarbamylase gene. Human Mutation. 4(1). 57–60. 42 indexed citations
18.
Lemieux, Bernard, Robert Giguère, Denis Cyr, et al.. (1993). Screening Urine of 3-Week-Old Newborns: Lack of Association Between Sudden Infant Death Syndrome and Some Metabolic Disorders. PEDIATRICS. 91(5). 986–988. 7 indexed citations
19.
Tuchman, Mendel, et al.. (1992). Screening urine of 3-week-old newborns: Transient methylmalonic and hydroxyphenyllactic aciduria. Biochemical Medicine and Metabolic Biology. 48(1). 64–68. 5 indexed citations
20.
Tuchman, Mendel, et al.. (1991). Screening Newborns for Multiple Organic Acidurias in Dried Filter Paper Urine Samples: Method Development. Pediatric Research. 30(4). 315–321. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Leichsenring Breakdown of academic impact, for papers by Ellen Crushell Breakdown of academic impact, for papers by Tetsuya Ito Breakdown of academic impact, for papers by Martti Kekomäki Breakdown of academic impact, for papers by Derek A. Wong Breakdown of academic impact, for papers by Ronald Bellisario Breakdown of academic impact, for papers by Joseph L. Perrotto Breakdown of academic impact, for papers by S Mantagos Breakdown of academic impact, for papers by Patricia S. Latham Breakdown of academic impact, for papers by Barbara Döring
Rankless by CCL
2026